FDA
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
-
-
-
-
-
-
-
OPKO Health and Entera Bio abstract selected for ESPEN Congress
-
-
-
-
-
-
-
Labcorp (LH) Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
-
-
-
-
-
-
-
Entera Bio Ltd. (ENTX) and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin Peptide Tablet Candidate
-
-
-
-
-
-
-
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
-
-
-
-
-
-
-
Pfizer (PFE) and OPKO (OPK) Announce FDA Approval of NGENLA
-
-
-
-
-
-
-
BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

